Playing Football Tied to Higher Risk of Parkinsonism, Parkinson Disease
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 15, 2023 -- Past participation in football is associated with higher odds of having a reported parkinsonism or Parkinson disease (PD) diagnosis, according to a study published online Aug. 11 in JAMA Network Open.
Hannah J. Bruce, from the Boston University Chobanian & Avedisian School of Medicine, and colleagues evaluated the association between football participation and self-reported parkinsonism or PD diagnosis. Analysis included 1,875 men who endorsed playing any organized sport (including football in 729 men).
The researchers found that a history of playing football was associated with higher odds of having a parkinsonism or PD diagnosis (odds ratio [OR], 1.61). Longer duration of play was associated with higher odds of having a parkinsonism or PD diagnosis (OR, 1.12), overall, and among football players (OR, 1.12). Playing football at a higher level of play further heightened odds of having parkinsonism or PD (OR, 2.93).
"The findings suggest that American football participation might be a risk factor for developing parkinsonism or PD," the authors write. "Prospective research among community-based samples that objectively evaluate parkinsonism and PD in former American football players across different levels of play will clarify the observed associations."
Two authors disclosed ties to the biotechnology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
American Academy of Neurology, April 13-18
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians...
Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease
THURSDAY, April 11, 2024 -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease...
Lixisenatide Reduces Motor Disability Progression in Parkinson Disease
THURSDAY, April 4, 2024 -- For patients with Parkinson disease, lixisenatide yields less progression of motor disability than placebo, according to a study published in the April...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.